CP
MANE

CenterBook Partners’s Veradermics Inc MANE Stock Holding History

CenterBook Partners’s Portfolio MANE Stock Details MANE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.21M Buy
+42,357
New +$3.97M 0.26% 102

Other funds holding MANE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

CenterBook Partners's MANE Position: Q2 2026 in Review

CenterBook Partners opened a new position in Veradermics Inc (MANE) in Q2 2026: 42,357 shares worth $5.21M. The stake represents 0.26% of the portfolio and ranks #102 among its holdings.

58 funds tracked by Wall St. Rank hold MANE as of Q2 2026.

  • CenterBook Partners held 42,357 shares of Veradermics Inc worth $5.21M as of Q2 2026.
  • Veradermics Inc was a new CenterBook Partners position in Q2 2026.
  • Veradermics Inc made up 0.26% of CenterBook Partners's portfolio in Q2 2026, its #102 holding.
  • 58 funds tracked by Wall St. Rank held Veradermics Inc as of Q2 2026.

Based on CenterBook Partners's 13F filing for Q2 2026, filed 11 Aug 2026.